LEDERMAN SETH (Chief Executive Officer) purchased 821.2% of their position (100K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market
Open‑market purchase worth $24.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/28/2022ACC: 0001387131-22-003991
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+100K
Net shares
Net buyer
$24.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+100K
Price / share
$0.24
Trade value
$24.50K
% of position
821.2%
3/25/2022
12.18K→112.18K
Total
Net shares
+100K
Net value
$24.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 3/25/2022 | P · Purchase | +100K | $0.24 | $24.50K | 821.2% | 12.18K | 112.18K |
| Total | +100K | $24.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)8
Common Stock, $0.001 par value
IndirectShares owned33.00
Common Stock, $0.001 par value
IndirectShares owned30.00
Common Stock, $0.001 par value
IndirectShares owned59.00
Common Stock, $0.001 par value
IndirectShares owned30.00
Common Stock, $0.001 par value
IndirectShares owned205.00
Common Stock, $0.001 par value
IndirectShares owned459.00
Common Stock, $0.001 par value
IndirectShares owned31.00
Common Stock, $0.001 par value
IndirectShares owned135K
Total
135.85K indirect135.85K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 33.00 | Indirect |
| Common Stock, $0.001 par value | 30.00 | Indirect |
| Common Stock, $0.001 par value | 59.00 | Indirect |
| Common Stock, $0.001 par value | 30.00 | Indirect |
| Common Stock, $0.001 par value | 205.00 | Indirect |
| Common Stock, $0.001 par value | 459.00 | Indirect |
| Common Stock, $0.001 par value | 31.00 | Indirect |
| Common Stock, $0.001 par value | 135K | Indirect |
| Total | 135.85K | 135.85K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported